Genoskin, a Toulouse, France and Salem, MA-based developer of human skin models as an alternative to animal testing, raised $8.7 million in a Series A fundraising round led by OCCTE FPCI Occidev Impacts, Captech Santé, and GSO Innovation.
More on Tech.eu →


